Perficient 的 2023 年第四季度盈利低于预期，净利润下降 12%，而 Privia Health Group 的盈利则更好，收入增长 21%。 Perficient's Q4 2023 earnings missed expectations with a 12% decrease in net income, while Privia Health Group reported better earnings with a 21% revenue increase.

Perficient 2023 年第四季度的盈利未达到预期，净利润下降 12% 至 2320 万美元，收入下降 5% 至 2.21 亿美元。 Perficient's Q4 2023 earnings missed expectations with a 12% decrease in net income to $23.2M, and a 5% decrease in revenues to $221M. Privia Health Group 公布的第四季度盈利好于预期，收入较上年增长 21.0% 至 4.408 亿美元。 Privia Health Group reported better than expected earnings for Q4, with a 21.0% revenue increase to $440.8M compared to the previous year. Perrigo 的 2024 财年盈利指引提供的每股收益为 2.50 美元至 2.65 美元，而普遍预期为 3.01 美元。 Perrigo's FY24 earnings guidance provided a range of $2.50 to $2.65 EPS, compared to the consensus estimate of $3.01. Privia Health Group 2024 财年的收入指引预计在 1.6-16.75 亿美元之间。 Privia Health Group's revenue guidance for FY 2024 is expected to be in the range of $1.6-1.675 billion.